Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users

Don Des Jarlais, S. R. Friedman, W. Hopkins

Research output: Contribution to journalArticle

Abstract

Intravenous drug users are the second largest risk group for the acquired immunodeficiency syndrome (AIDS) and a bridge to two other groups: children and heterosexual partners. In the absence of effective treatment or vaccines, control of the epidemic among drug users will rely on efforts to reduce needle sharing. However, the traditional image of intravenous drug users leads one to expect little or no risk reduction. We review characteristics of AIDS as a disease that impede efforts at risk reduction among drug users and report on current risk reduction among intravenous drug users in New York City. There has been a sustained increase in the demand for new, unused needles, as shown in the emergence of 'resealed' needles and in interviews with persons selling needles in illicit drug-purchasing areas.

Original languageEnglish (US)
Pages (from-to)755-759
Number of pages5
JournalAnnals of Internal Medicine
Volume103
Issue number5
StatePublished - Dec 1 1985

Fingerprint

Risk Reduction Behavior
Drug Users
Acquired Immunodeficiency Syndrome
Needles
Needle Sharing
Heterosexuality
Street Drugs
Vaccines
Interviews

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. / Des Jarlais, Don; Friedman, S. R.; Hopkins, W.

In: Annals of Internal Medicine, Vol. 103, No. 5, 01.12.1985, p. 755-759.

Research output: Contribution to journalArticle

@article{43b292ea317747f3bc177ed216a8cad5,
title = "Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users",
abstract = "Intravenous drug users are the second largest risk group for the acquired immunodeficiency syndrome (AIDS) and a bridge to two other groups: children and heterosexual partners. In the absence of effective treatment or vaccines, control of the epidemic among drug users will rely on efforts to reduce needle sharing. However, the traditional image of intravenous drug users leads one to expect little or no risk reduction. We review characteristics of AIDS as a disease that impede efforts at risk reduction among drug users and report on current risk reduction among intravenous drug users in New York City. There has been a sustained increase in the demand for new, unused needles, as shown in the emergence of 'resealed' needles and in interviews with persons selling needles in illicit drug-purchasing areas.",
author = "{Des Jarlais}, Don and Friedman, {S. R.} and W. Hopkins",
year = "1985",
month = "12",
day = "1",
language = "English (US)",
volume = "103",
pages = "755--759",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users

AU - Des Jarlais, Don

AU - Friedman, S. R.

AU - Hopkins, W.

PY - 1985/12/1

Y1 - 1985/12/1

N2 - Intravenous drug users are the second largest risk group for the acquired immunodeficiency syndrome (AIDS) and a bridge to two other groups: children and heterosexual partners. In the absence of effective treatment or vaccines, control of the epidemic among drug users will rely on efforts to reduce needle sharing. However, the traditional image of intravenous drug users leads one to expect little or no risk reduction. We review characteristics of AIDS as a disease that impede efforts at risk reduction among drug users and report on current risk reduction among intravenous drug users in New York City. There has been a sustained increase in the demand for new, unused needles, as shown in the emergence of 'resealed' needles and in interviews with persons selling needles in illicit drug-purchasing areas.

AB - Intravenous drug users are the second largest risk group for the acquired immunodeficiency syndrome (AIDS) and a bridge to two other groups: children and heterosexual partners. In the absence of effective treatment or vaccines, control of the epidemic among drug users will rely on efforts to reduce needle sharing. However, the traditional image of intravenous drug users leads one to expect little or no risk reduction. We review characteristics of AIDS as a disease that impede efforts at risk reduction among drug users and report on current risk reduction among intravenous drug users in New York City. There has been a sustained increase in the demand for new, unused needles, as shown in the emergence of 'resealed' needles and in interviews with persons selling needles in illicit drug-purchasing areas.

UR - http://www.scopus.com/inward/record.url?scp=0022406437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022406437&partnerID=8YFLogxK

M3 - Article

VL - 103

SP - 755

EP - 759

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -